JATT III Acquisition (Stock-Only)

Print
General Information
Business:

(Incorporated in the Cayman Islands)

We are a newly organized healthcare SPAC with a focus on biotech and the broader life sciences.

Someit Sidhu, our CEO and chairman, is the founder of  numerous healthcare companies. He is the CEO as well as the founder of Khanda Therapeutics

(Note: JATT III Acquisition filed its S-1 on Aug. 10, 2026, and disclosed the terms of its SPAC IPO – 6 million shares at $10.00 each – to raise $60 million. The company is not offering units with warrants or rights included.)

 
Industry: BLANK CHECKS
Employees: 0
Founded: 2026
Contact Information
Address 153 Central Avenue C/O 56 Westfield, NJ 07091
Phone Number 201-688-0364
Web Address
View Prospectus: JATT III Acquisition (Stock-Only)
Financial Information
Market Cap $77.25mil
Revenues $0.0 mil (last 12 months)
Net Income $0.0 mil (last 12 months)
IPO Profile
Symbol JTTT
Exchange NASDAQ
Shares (millions): 6.0
Price range $10.00 - $10.00
Est. $ Volume $60.0 mil
Manager / Joint Managers Guggenheim Securities
CO-Managers
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change